Neogen Chemicals Ltd
NSE:NEOGEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (5.3), the stock would be worth ₹1 595.61 (3% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 5.5 | ₹1 646.4 |
0%
|
| 3-Year Average | 5.3 | ₹1 595.61 |
-3%
|
| 5-Year Average | 5.8 | ₹1 723.24 |
+5%
|
| Industry Average | 1.8 | ₹551.47 |
-67%
|
| Country Average | 2.9 | ₹860.17 |
-48%
|
Forward EV/S
Today’s price vs future revenue
| Today's Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
₹36.9B
|
/ |
Jan 2026
₹8.2B
|
= |
|
|
₹36.9B
|
/ |
Mar 2026
₹8.5B
|
= |
|
|
₹36.9B
|
/ |
Mar 2027
₹13.4B
|
= |
|
|
₹36.9B
|
/ |
Mar 2028
₹22.5B
|
= |
|
|
₹36.9B
|
/ |
Mar 2029
₹29.7B
|
= |
|
|
₹36.9B
|
/ |
Mar 2030
₹32.8B
|
= |
|
|
₹36.9B
|
/ |
Mar 2031
₹36.4B
|
= |
|
|
₹36.9B
|
/ |
Mar 2032
₹44.1B
|
= |
|
Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
|
Neogen Chemicals Ltd
NSE:NEOGEN
|
43.6B INR | 5.5 | 220.1 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
83.3B USD | 4 | 32.4 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
13T JPY | 4.7 | 27.3 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
75.5B USD | 5.1 | 36.4 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 0.8 | 10.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
278.5B CNY | 1.6 | 21.2 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
26B CHF | 3.9 | 24.3 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 9.4 | 54.8 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.4T INR | 6.7 | 61.6 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
24.6B USD | 1.8 | 15.6 | |
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR | 1.9 | 17.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.6 |
| Median | 2.9 |
| 70th Percentile | 5 |
| Max | 55 686.2 |
Other Multiples
Neogen Chemicals Ltd
Glance View
Neogen Chemicals Ltd. engages in the manufacture of specialty chemicals which are used in pharmaceutical, engineering, and agro chemical industries. The Company’s products include organic chemicals, advance intermediates, inorganic chemicals, chemistries and grignard reagents. The firm operates through three segments: organic chemicals, inorganic chemicals, and custom synthesis and manufacturing. Organic chemicals segment is involved in the manufacturing of organic bromine-based compounds, advanced intermediates, specialty compounds and Grignard reagents. The inorganic chemicals segment is involved in manufacturing inorganic lithium and bromine salts. Custom synthesis and manufacturing segment is involved in developing and manufacturing new processes and customized products.
